PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Penn study identifies new trigger for breast cancer metastasis

2013-11-08
(Press-News.org) Contact information: Katherine Unger Baillie
kbaillie@upenn.edu
215-898-9194
University of Pennsylvania
Penn study identifies new trigger for breast cancer metastasis

For years, scientists have observed that tumor cells from certain breast cancer patients with aggressive forms of the disease contained low levels of mitochondrial DNA. But, until recently, no one was able to explain how this characteristic influenced disease progression.

Now, University of Pennsylvania researchers have revealed how a reduction in mitochondrial DNA content leads human breast cancer cells to take on aggressive, metastatic properties. The work, published in the journal Oncogene, breaks new ground in understanding why some cancers progress and spread faster than others and may offer clinicians a biomarker that would distinguish patients with particularly aggressive forms of disease, helping personalize treatment approaches.

The study was led by the Penn School of Veterinary Medicine's Manti Guha, a senior research investigator, and Narayan Avadhani, Harriet Ellison Woodward Professor of Biochemistry in the Department of Animal Biology. Additional Penn Vet collaborators included Satish Srinivasan, Gordon Ruthel, Anna K. Kashina and Thomas Van Winkle. They teamed with Russ P. Carstens of Penn's Perelman School of Medicine and Arnulfo Mendoza and Chand Khanna of the National Cancer Institute.

Mitochondria, the "powerhouses" of mammalian cells, are also a signaling hub. They are heavily involved in cellular metabolism as well as in apoptosis, the process of programmed cell death by which potentially cancerous cells can be killed before they multiply and spread. In addition, mitochondria contain their own genomes, which code for specific proteins and are expressed in coordination with nuclear DNA to regulate the provision of energy to cells.

In mammals, each cell contains between 100 and 1,000 copies of mitochondrial DNA, but previous research had found that as many as 80 percent of people with breast cancer have low mitochondrial DNA, or mtDNA, content.

To gain an understanding of the mechanism that connects low mtDNA levels with a cellular change that leads to cancer and metastasis, Guha, Avadhani and their colleagues set up two systems by which they could purposefully reduce the amount of mtDNA in a cell. One used a chemical to deplete the DNA content, and another altered mtDNA levels genetically. They compared normal, non-cancer-forming human breast tissue cells with cancerous breast cells using both of these treatments, contrasting them with cells with unmanipulated mtDNA.

The differences between cells with unmodified and reduced mtDNA levels were striking, the researchers found. The cells in which mtDNA was reduced had altered metabolism and their structure appeared disorganized, more like that of a metastatic cancer cell. Even the non-tumor-forming breast cells became invasive and more closely resembled cancer cells. Significantly, cells with reduced mtDNA became self-renewing and expressed specific cell surface markers characteristic of breast cancer stem cells.

"Reducing mitochondrial DNA makes mammary cells look like cancerous stem cells," Avadhani said. "These cells acquire the characteristics of stem cells, that is the ability to propagate and migrate, in order to begin the process of metastasis and move to distal sites in the body."

"Most patients who had low copy numbers of mitochondrial DNA have a poor disease prognosis," Guha said. "We've shown a causal role for this mitochondrial defect and identified a candidate biomarker for aggressive forms of the disease. In the future, mtDNA and the factors involved in mitochondrial signaling may serve as markers of metastatic potential and novel points for therapeutic intervention of cancer stem cells. Since the specific inducers of cancer stem cells, which are key drivers of metastasis, remain elusive, our current findings are a significant advancement in this area."

No two breast cancers are exactly alike, so having a way to recognize patients who are at high-risk for developing particularly invasive and rapidly metastasizing cancers could help physicians customize treatments. In addition, researchers are currently filling in the unknown components of the signaling pathway linking a cell's mitochondrial DNA levels and its involvement in metastatic disease.

As a next step, Guha, Avadhani and colleagues plan to extend this study to in vivo mouse models and will also investigate these mechanisms in tumor samples from human breast cancer patients.



INFORMATION:

This study was funded by the National Institutes of Health and the Harriet Ellison Woodward Trust.



ELSE PRESS RELEASES FROM THIS DATE:

Dialysis for the elderly: New evidence from Mayo Clinic to guide shared decision-making

2013-11-08
Dialysis for the elderly: New evidence from Mayo Clinic to guide shared decision-making ROCHESTER, Minn. — New research from Mayo Clinic finds that half of elderly patients who start dialysis after age 75 will die within one year. The findings are being presented this ...

Gut reaction

2013-11-08
Gut reaction Texas A&M, other scientists study factors influencing intestinal microbes COLLEGE STATION — Texas A&M University and University of North Carolina School of Medicine scientists have completed a study on the effect of diet complexity ...

NASA sees former Tropical Depression 30W entering Indian Ocean

2013-11-08
NASA sees former Tropical Depression 30W entering Indian Ocean Now a remnant low pressure area, former Tropical Depression 30W may get new another life in another ocean. NASA's Aqua satellite captured an infrared image of the storm that showed strong circulation and ...

Hope builds for a drug that might shut down a variety of cancers

2013-11-08
Hope builds for a drug that might shut down a variety of cancers Cancer cells 'go to sleep' when crucial set of molecules is targeted NEW YORK (November 7, 2013) -- The most frequently mutated gene across all types of cancers is a gene called p53. Unfortunately ...

UMMS researchers answer century old question about 3D structure of mitotic chromosomes

2013-11-08
UMMS researchers answer century old question about 3D structure of mitotic chromosomes New evidence shows that chromosomes assemble into linearly organized, compressed chromatin loops during the metaphase stage of cell division

Babies named for fathers but not mothers reflect US cultural ideologies

2013-11-08
Babies named for fathers but not mothers reflect US cultural ideologies November 7, 2013 - From Cal Ripkin, Jr., to MLK to Robert Downey, Jr., finding men named after their fathers is easy. Children named after men in the family ...

Children born prematurely face up to a 19 times greater risk of retinal detachment later in life

2013-11-08
Children born prematurely face up to a 19 times greater risk of retinal detachment later in life First large population-based study investigating long-term risks supports need for ophthalmologic follow-up of children and adults born before 32 weeks of gestation SAN ...

New method predicts time from Alzheimer's onset to nursing home, death

2013-11-08
New method predicts time from Alzheimer's onset to nursing home, death Draws on information from a single patient visit NEW YORK, NY (Nov. 7, 2013) – A Columbia University Medical Center-led research team has clinically validated a new method ...

NASA satellites see Super-Typhoon Haiyan lashing the Philippines

2013-11-08
NASA satellites see Super-Typhoon Haiyan lashing the Philippines Super-Typhoon Haiyan was lashing the central and southern Philippines on Nov. 7 bringing maximum sustained winds of a Category 5 hurricane. NASA is providing visible, infrared and microwave satellite ...

Mayo Clinic: Less-invasive option as effective as esophagus removal in early esophageal cancer

2013-11-08
Mayo Clinic: Less-invasive option as effective as esophagus removal in early esophageal cancer JACKSONVILLE, Fla. — Use of a minimally invasive endoscopic procedure to remove superficial, early stage esophageal cancer is as effective as surgery that takes out and rebuilds ...

LAST 30 PRESS RELEASES:

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

Mission accomplished for the “T2T” Hong Kong Bauhinia Genome Project

[Press-News.org] Penn study identifies new trigger for breast cancer metastasis